Square 1 Bank, a banking partner to entrepreneurs and the venture capital community, provided a credit facility to RTP-based Heat Biologics, Inc., a clinical-stage immunotherapy company. Proceeds of the credit facility will be used to support ongoing clinical trials and company growth.

“We were immediately impressed with the company’s management team and their cutting edge technology which has the potential to disrupt the way cancer and other diseases are treated. We are pleased to be Heat Biologics’ financial partner.”

Launched in 2008, Heat Biologics focuses on developing its novel off-the-shelf ImPACT(Immune Pan-Antigen Cytotoxic Therapy) therapeutic vaccines to combat a wide range of cancers and infectious diseases. The company relocated its headquarters from Miami, FL to Chapel Hill, NC in 2010.

“Square 1 Bank has been an excellent partner for Heat Biologics by providing valuable, strategic advice related to finance. The team at Square 1 listened to our needs and provided creative solutions that met the strategic goals of our company,” said Jeff Wolf, founder and chief executive officer.

Mara Huntington, senior vice president in Square 1’s Life Sciences division added, “We were immediately impressed with the company’s management team and their cutting edge technology which has the potential to disrupt the way cancer and other diseases are treated. We are pleased to be Heat Biologics’ financial partner.”

Square 1 Bank is a full service commercial bank dedicated to serving the financial needs of the venture capital community and entrepreneurs in all stages of growth and expansion.